• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Long-Term Disease Control in a Patient With Recurrent Bone-Only Oligometastatic Nasopharyngeal Carcinoma.

作者信息

Khot Ashish, Love Charito, Garg Madhur K, Haigentz Missak

机构信息

Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY.

Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY

出版信息

J Clin Oncol. 2016 Feb 1;34(4):e25-6. doi: 10.1200/JCO.2013.51.3549. Epub 2014 Jun 9.

DOI:10.1200/JCO.2013.51.3549
PMID:24912898
Abstract
摘要

相似文献

1
Long-Term Disease Control in a Patient With Recurrent Bone-Only Oligometastatic Nasopharyngeal Carcinoma.复发性仅骨寡转移鼻咽癌患者的长期疾病控制
J Clin Oncol. 2016 Feb 1;34(4):e25-6. doi: 10.1200/JCO.2013.51.3549. Epub 2014 Jun 9.
2
[Clinical characteristics and salvage treatment for recurrent nasopharyngeal carcinoma].[复发性鼻咽癌的临床特征及挽救性治疗]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2012 Mar;47(3):261-4.
3
Epstein-Barr virus-specific adoptive immunotherapy for recurrent, metastatic nasopharyngeal carcinoma.针对复发性、转移性鼻咽癌的爱泼斯坦-巴尔病毒特异性过继性免疫疗法。
Cancer. 2017 Jul 15;123(14):2642-2650. doi: 10.1002/cncr.30541. Epub 2017 Feb 21.
4
[Advance in diagnosis and management of local recurrent nasopharyngeal carcinoma].[局部复发性鼻咽癌的诊断与治疗进展]
Ai Zheng. 2004 Feb;23(2):230-4.
5
Concurrent chemoradiotherapy in locoregionally recurrent nasopharyngeal carcinoma.
Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1312-8. doi: 10.1016/j.ijrobp.2004.01.037.
6
The palliative role of PDT in recurrent advanced nasopharyngeal carcinoma: case series.光动力疗法在复发性晚期鼻咽癌中的姑息作用：病例系列。
Photodiagnosis Photodyn Ther. 2012 Jun;9(2):142-7. doi: 10.1016/j.pdpdt.2012.01.004. Epub 2012 Mar 28.
7
[Evaluation of induction chemotherapy with vinorelbine plus cisplatin (NP) or docetaxel plus cisplatin (TP) combined with concurrent chemoradiotherapy for patients with locally advanced nasopharyngeal carcinoma].[长春瑞滨联合顺铂（NP）或多西他赛联合顺铂（TP）诱导化疗联合同期放化疗治疗局部晚期鼻咽癌患者的疗效评估]
Zhonghua Zhong Liu Za Zhi. 2013 Aug;35(8):623-6.
8
Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy.挽救性调强放疗治疗复发性鼻咽癌的长期治疗结果。
Eur J Cancer. 2012 Dec;48(18):3422-8. doi: 10.1016/j.ejca.2012.06.016. Epub 2012 Jul 25.
9
Durable response to first-line nivolumab in a patient with oligometastatic PD-L1 positive nasopharyngeal cancer.寡转移PD-L1阳性鼻咽癌患者对一线纳武单抗的持久反应。
Oral Oncol. 2018 Dec;87:204-206. doi: 10.1016/j.oraloncology.2018.10.019. Epub 2018 Oct 25.
10
Concurrent Chemoradiotherapy for Loco-regionally Advanced Nasopharyngeal Carcinoma: Treatment Outcomes and Prognostic Factors.局部晚期鼻咽癌同步放化疗：治疗结果与预后因素
Asian Pac J Cancer Prev. 2018 Jun 25;19(6):1591-1599. doi: 10.22034/APJCP.2018.19.6.1591.

引用本文的文献

1
Efficacy of local therapy to metastatic foci in nasopharyngeal carcinoma: large-cohort strictly-matched retrospective study.局部治疗对鼻咽癌转移灶的疗效：大型队列严格匹配回顾性研究。
Ther Adv Med Oncol. 2022 Jul 15;14:17588359221112486. doi: 10.1177/17588359221112486. eCollection 2022.
2
An Exploratory Study of Refining TNM-8 M1 Categories and Prognostic Subgroups Using Plasma EBV DNA for Previously Untreated De Novo Metastatic Nasopharyngeal Carcinoma.利用血浆EBV DNA对初治的新发转移性鼻咽癌细化TNM-8 M1分类和预后亚组的探索性研究
Cancers (Basel). 2022 Apr 11;14(8):1923. doi: 10.3390/cancers14081923.
3
Optimizing the treatment mode for de novo metastatic nasopharyngeal carcinoma with bone-only metastasis.
优化仅有骨转移的初治转移性鼻咽癌的治疗模式。
BMC Cancer. 2022 Jan 4;22(1):35. doi: 10.1186/s12885-021-09152-1.
4
Local treatment of metastases plus systemic chemotherapy on overall survival of patients with metastatic nasopharyngeal carcinoma.局部治疗联合全身化疗对转移性鼻咽癌患者总生存期的影响。
Head Neck. 2021 Aug;43(8):2423-2433. doi: 10.1002/hed.26706. Epub 2021 May 3.
5
Establishing M1 stage subdivisions by incorporating radiological features and Epstein-Barr virus DNA for metastatic nasopharyngeal carcinoma.通过纳入放射学特征和爱泼斯坦-巴尔病毒DNA对转移性鼻咽癌进行M1期细分。
Ann Transl Med. 2020 Feb;8(4):83. doi: 10.21037/atm.2020.01.13.
6
Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein-Barr virus DNA level and tumor response to palliative chemotherapy.基于 Epstein-Barr 病毒 DNA 水平和姑息性化疗后肿瘤缓解情况，识别初诊转移性鼻咽癌患者中局部治疗原发肿瘤的最佳候选者：一项回顾性队列研究。
BMC Cancer. 2019 Jan 21;19(1):92. doi: 10.1186/s12885-019-5281-5.
7
Subdivision of Nasopharyngeal Carcinoma Patients with Bone-Only Metastasis at Diagnosis for Prediction of Survival and Treatment Guidance.初诊时仅有骨转移的鼻咽癌患者的细分，以预测生存和指导治疗。
Cancer Res Treat. 2019 Oct;51(4):1259-1268. doi: 10.4143/crt.2018.652. Epub 2019 Jan 4.